Deutsches Konsortium für Translationale Krebsforschung

Heidelberg, Germany · 1 author

Deutsches Konsortium für Translationale Krebsforschung (Heidelberg, Germany): 1 author and 1 paper in the de novo peptide sequencing catalog.

Authors (1)

Annette Paschen

Papers (1)

• SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells (2025, Frontiers in Immunology)

Seen in the charts

• Where the work happens
• Browse all authors

Back to the full map